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Background: Breast cancer is the most common disease of women around the world. On the other hand, 
benign breast diseases also constitute a wide range of breast pathologies that precise information on them is 
important. This study is conducted aiming to examine the breast pathology reports and determine the frequency 
of various breast diseases and its relationship with some clinicopathologic parameters in Imam Reza Hospital 
of army of the Islamic Republic of Iran in a period of 4 years. 
Methods: Imam Reza Hospital is a referral center for Army employees in Iran. This study is a retrospective 
descriptive study on patients who undertook biopsy or breast surgery during 2012-2015 in Imam Reza 
Hospital. After reviewing pathology reports and patient records and completing the required information, a 
total of 188 patients with 230 samples of breast tissue were included in this study. 
Results: During the period, 230 samples of breast tissue from 188 patients were sent to the pathology 
department. 195 samples (84.8%) were related to female patients and 35 samples (15.2%) to males.  
112 samples (48.7%) were related to the left breast and 118 samples to the right (51.3%). The average size of 
tissues was 11.82 ± 8.64 cm. The mean age of patients was 42 ± 14. 
Conclusions: In this study, a statistically significant relationship exists between the patient sex and final 
diagnosis, patient age group and final diagnosis, and cell differentiation grade and lymph node metastasis along 
with samples. In the pathology reports in the center, cell differentiation grade of tumor was completely 
matched with Nottingham Grading System. 
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Introduction 
Breast cancer is the most common disease of women 
around the world. After skin cancer, breast cancer is 
the most common malignancy in women (1), after lung 
cancer, it is the second leading cause of cancer death in 
women aged 20-59 years old (2). According to the 
statistics of the World Health Organization, more than 
1.2 million patients are annually diagnosed with breast 
cancer and more than 500 thousand people die of the 
disease, and the risk is increasing in developing 
countries unlike the United States (3). The incidence of 
cancer rises with aging so that we reach from 1 in 230 
cases in the fourth decade of life to 1 in 30 in the 
seventh decade (4). Previous studies in Iran’s 
population indicate the prevalence of 17 in  
100 thousands of women with peak prevalence in the 
age group 45-54 years old (5). However, breast cancer 
is the most common cancer in Iran and includes 21.4% 
of all cancer malignancies among women (6). 
The incidence of breast cancer in Iranian women 
occurs a decade sooner than the developing countries. 
It also reveals the importance of study and research in 
this area more than before (7). Breast diseases affect 
not only women but also men. Male breast cancer 
makes up 1% of all breast cancer cases in Western 
countries (8). Breast cancer treatment requires a 
widespread recognition of the disease at the time of 
diagnosis (9). Although clinical examination and 
radiological findings play an important role in 
providing information about the types of breast 
diseases, making treatment decisions is largely 
dependent on pathological findings and data from the 
sample examination. Determining principled and 
correct therapeutic method requires accurate and 
precise data from tissue, type of tumor, surgery and a 
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full description of histologic evaluation such as 
calcification, necrosis, grade, perineural and vascular 
invasion, and lymphatic involvement (10). 
On the other hand, benign breast diseases also 
constitute a wide range of breast pathologies that 
precise information on them is important. For example, 
fibroadenomas form 68% of all breast lumps to  
44-94% of all breast biopsies diagnose fibroadenoma 
(11). According to available reports, from one out of 
every six women in society undergoes biopsy due to 
breast problems and diagnostic results in about 75-80% 
of cases are reported to be benign (12). Precise 
differentiation of benign lesions from malignant by 
physical examination is difficult to a large extent, and 
this signifies the importance of the precise histological 
diagnosis (13). Another important point that must be 
noted is if the breast benign lesions increase the risk of 
breast cancer in the future or not. Many experts in the 
field of breast diseases know that certain types of 
benign breast changes are more related to malignant 
lesions (14). Simple hyperplasia increases cancer risk 
partly while atypical hyperplasia increases absolute 
cancer risk by 29% in 25 years; therefore, precise 
pathological diagnosis and its correlation with clinical 
parameters in follow-up of patients with breast lesions 
is very important (15). Hence, this study has been 
designed and conducted to investigate pathological 
reports of patients with different types of breast lesions. 
It is hoped the results of this study provide a correct 
view of the types of breast diseases and their clinical 
and histological characteristics. 
 
Materials and Methods 
Imam Reza Hospital (501 Artesh of Islamic Republic 
of Iran) is a referral center for Army employees in Iran. 
Hence, the patients who refer to this center can make a 
good sample of all Army employees. This study is a 
retrospective descriptive study on patients who 
undertook biopsy or breast surgery during 2012-2015 
(since early 2012 to late 2015) in Imam Reza Hospital 
(501 Artesh of Islamic Republic of Iran). To do this, 
referring to the hospital pathology ward and examining 
samples’ registries, all pathological reports of the 
patients in this period available in hospital pathology 
ward were studied, and samples prepared from breast 
tissue were separated. Then, data collection form was 
completed based on the information in pathology 
reports, including patients’ age, sex, tumor location, 
sample size, final diagnosis and tumor size, tumor 
grade, Nottingham score, lymph node involvement and 
vascular, or perineural invasion in the case of tumoral 
tissues. Meanwhile, a number of samples were 
deficient in information that was corrected and 
completed by referring to patients’ admission records 
at the archives and phone call to patients. Finally, 188 
patients were included into the study with 230 samples. 
The reason for this difference is in the number of 
patients and the number of samples, sending multiple 
samples from one patient. At least two samples were sent 
to the pathology ward from 43 patients, and the number of 
samples of some patients also reached 4. Collected data 
were analyzed using SPSS (version 23, IBM Corporation, 
Armonk, NY, USA) and chi-square test.  
 
Results 
During the period, 230 samples of breast tissue from 
188 patients were sent to the pathology department for 
pathological evaluation. 195 samples (84.8%) were 
related to female patients and 35 samples (15.2%) to 
males. 112 samples (48.7%) were related to the left 
breast and 118 samples to the right (51.3%). Among all 
tissue sent to pathology regardless of the patient,  
62 fibrocystic changes (27%), 55 non-specific tissues 
(23.9%), 50 cases of invasive ductal carcinoma (IDC) 
(21.7%), 26 cases (11.3%) of gynecomastia, 22 cases 
(9.6%) of fibroadenomas, 8 cases (3.5%) of ductal 
carcinoma in situ (DCIS), 5 invasive lobular carcinoma 
(ILC) (2.2%), and 2 cases (0.9%) of papillary 
carcinoma were reported. The average size of tissues 
was 11.82 cm with a standard deviation of 8.64. The 
largest sample was about 40 cm. The size of sent 
samples and patients’ age by the final diagnosis is 
given in Table 1. In the meantime, the size of tumors 
with a diagnosis of DCIS had the most, and the size of 
tumors with fibroadenoma had the lowest average size. 
The highest mean age was related to the patients with 
papillary carcinoma and lowest average age to the 
patients with gynecomastia. 
On the relationship between patients’ gender and 
final diagnosis of the sent tissue, it can be noted that all 
patients who were diagnosed with gynecomastia, were 
male. Among patients with IDC, there was also a male 
patient. In fact, 1 out of 50 samples with IDC was 
related to male patient (2%). Among the tissues with 
non-specific diagnosis, 47 samples (85.5%) were 
related to the female patients and 8 (14.5%) to males 
(Table 1). No significant correlation was found in the 
relationship between the lesion location and final 
diagnosis of the tissue (Table 1). 
Following results were obtained on the relationship 
between patients’ age and final diagnosis after dividing 
the patients into two age groups under 50 years of age and 
patients over 50 which were statistically significant  
(P < 0.001): Among 62 cases of tissue with fibrocystic 
changes, 48 cases (77.4) were under 50 years old and 14 
(22.6%) above 50. Among 22 samples with 
fibroadenoma, 21 samples (95.5%) were under 50 years 
old and 1 sample (4.5%) was above 50. Among 26 
gynecomastia samples, 24 samples (92.3%) were under 
50, and 2 samples (7.7%) were above 50. Among 50 
samples with IDC diagnosis, 25 samples (50%) were 
under 50 years old and 25 samples (50%) were above 50. 
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Among 8 DCIS samples, 3 samples (37.5%) were 
under 50 and 5 samples (62.5%) were above 50. 
Among 5 ILC samples, 3 samples (60%) were under 50 
years old and 2 samples (40%) were above 50. Among 
48 samples with non-specific diagnosis 37 samples 
(67.3%) were under 50 and 18 samples (32.7%) were 
above 50. Among 2 papillary carcinoma samples,  
1 sample (50%) was under 50 years old and 1 sample 
(50%) was above 50. 
In studying samples with a diagnosis of malignant 
breast tissue, from 65 samples, 8 samples (12.3%) were 
DCIS, 50 samples (76.9%) IDC, 5 (7.7%) ILC, and  
2 (3.1%) papillary carcinoma. 
On the tumor size in sent samples in the final 
diagnosis, the maximum size was related to the 
samples with DCIS with an average size of 4 cm and 
the minimum size related to two papillary carcinoma 
samples with an average size of 2.45 cm (Table 2). 
In relation to the grade of tumoral tissues,  
6 samples (9.2%) were grade 1, 32 (49.2%) grade 2, 
and 27 (41.5%) grade 3. 
On the relationship between the final diagnosis of 
tumoral tissue and grade, in 8 samples with a diagnosis 
of DCIS, 5 samples (62.5%) had a grade 2, and 3 
samples (37.5%) grade 3. In 50 samples with a 
diagnosis of IDC 6 samples (12%) were grade 1, 20 
samples (40%) were in grade 2, and 24 samples (48%) 
were in grade 3. In 5 samples with ILC diagnosis and 2 
samples with the diagnosis of papillary carcinoma, all 
samples were in grade 2. There was not any 
statistically significant relationship between final 
diagnosis of tumoral tissue and their stages (Table 2). 
In the case of metastasis of sent lymph nodes in 
patients with breast cancer, 36 samples (55.4%) were 
along with lymph node metastasis with malignant cells 
and 29 samples (44.6%) without lymph node 
metastasis. 
In the case of vascular or perineural invasion, it was 
reported in 25 cases (38.5%) and in about 40 samples 
(61.5%), the invasion was not reported. 
 On the relationship between final diagnosis and 
lymph nodes involvement by tumor tissue, 2 lymph 
node metastases were reported out of 8 DCIS. Among 
50 IDC, in 32 samples (64%) involvement of lymph 
nodes was reported. Among 5 ILC, 2 samples (40%) 
had lymph node involvement, and both papillary 
carcinomas lacked lymph node involvement. In 
general, from 65 samples of breast cancer tissue, 36 
cases (55.4) had lymph node metastasis and 29 cases 
(44.6%) without lymph node metastasis. No significant 
relationship was found between final diagnosis of 
tumor and lymph node metastasis (Table 2). 
On the relationship between vascular or perineural 
invasion and final diagnosis, from 8 DCIS cases, only 2 
cases of vascular or perineural invasion have been 
reported. Among 50 ILC in 23 samples (46%) 
perineural or vascular invasion was reported. From 5 
samples with ILC diagnosis, none had vascular or 
perineural invasion, and both either papillary 
carcinoma lacked vascular or perineural invasion. 
Finally, among 65 malignant samples, 25 samples 
(38.5%) had vascular or perineural invasion and 40 
samples (61.5%) lacked it. No significant relationship 
was found between final diagnosis of tumor and 
vascular or perineural invasion (Table 2). 
About the relationship between the lesion site and 
the lymph nodes involvement by tumoral tissue, 14 out 
of 29 samples (48.3%) from the left breast had lymph 
node metastasis and 22 out of 36 samples (61.1%) sent 
from the right breast, had lymph node metastasis. This 
difference was not statistically significant in the 
samples (Table 3) (P value Fisher’s Exact test = 0.327). 
About the relationship between lesion site and the 
vascular or perineural invasion, 11 out of 29 samples 
(37.9%) from the left breast had vascular or perineural 
invasion and 14 out of 36 samples (38.9%) sent from 
the right breast had such a situation. This difference 
was not statistically significant in the samples (Table 3) 
(P value Fisher’s exact test = 1.000). 
On the relationship between tumor grade and lymph 
node metastasis, 5 out of 6 samples (83.3%) with grade 
1 had lymph node metastasis and 1 was reported 
without involvement. Among 32 grade 2 samples, 13 
samples (40.6%) were reported with lymph node 
involvement and 19 samples (59.4%) lacked that. 
Among 27 samples with grade 3 diagnosis, 18 samples 
(66.7%) were reported with lymph node involvement 
and 9 samples (33.3%) lacked that. The relationship 
between tumor grade and lymph node metastasis was 
statistically significant (P = 0.047). 
On the relationship between tumor grade and 
vascular or perineural invasion, 3 out of 6 samples with 
grade 1 were involved and 3 were reported without 
involvement. Among 32 grade 2 samples, 8 samples 
(25%) were reported with vascular or perineural 
involvement and 24 samples (75%) lacked that. Among 
27 samples with grade 3 diagnosis, 14 samples (51.9%) 
were reported with vascular or perineural involvement 
and 13 samples (48.1%) lacked that. There was not any 
statistically significant relationship between tumor 
grade and vascular or perineural invasion (Table 3). 
On the relationship between patient age and lymph 
node metastasis, the average age of patients with lymph 
node metastasis was 48 with a standard deviation of 12 
and the average age of the patients without lymph node 
metastasis was 55 with standard deviation of 13 that 
the results were not statistically significant (Table 3)  
(P = 0.058). 
On the relationship between patients’ age and 
vascular and perineural invasion, mean age of 
patients with invasion was 50 with a standard 
deviation of 13 and mean age of patients with no 
invasion was 52 with standard deviation 13 that was 
not statistically significant.  
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Table 1. Clinicopathologic features of breast lesions 
Variables 
Non-S Fad Gyn FCC IDC ILC DCIS PC Total 
P-value 
Frequency (%) Frequency (%) Frequency (%) Frequency (%) Frequency (%) Frequency (%) Frequency (%) Frequency (%) Frequency (%) 
Frequency           
Patient 44 (23.4) 21 (11.2) 17 (9) 43 (22.9) 49 (26.1) 5 (2.7) 7 (3.7) 2 (1.1) 188 (100)  
Sample 55 (23.9) 22 (9.6) 26 (11.3) 62 (27) 50 (21.7) 5 (2.2) 8 (3.2 2 (0.9) 230 (100)  
Location           
R 26 (47.3) 11 (50) 13 (50) 32 (51.6) 27 (54) 2 (40) 6 (75) 1 (50) 118 (51.3) 0.920 
L 29 (52.7) 11 (50) 13 (50) 30 (48.4) 23 (46) 3 (60) 2 (25) 1 (50) 112 (48.7) 
Sex           
F 47 (85.5) 22 (100) 0 (0) 62 (100) 49 (98) 5 (100) 8 (100) 2 (100) 195 (84.8) < 0.001 
M 8 (14.5) 0 (0) 26 (100) 0 (0) 1 (2) 0 (0) 0 (0) 0 (0) 35 (15.2) 
Age group           
< 50 37 (67.3) 21 (95.5) 24 (92.3) 48 (77.4) 25 (50) 3 (60) 3 (37.5) 1 (50) 162 (70.4) < 0.001 
> 50 18 (32.7) 1 (4.5) 2 (7.7) 14 (22.6) 25 (50) 2 (40) 5 (62.5) 1 (50) 68 (29.6) 
Size           
Mean ± SD 12.30 ± 9.34 3.07 ± 1.81 6.73 ± 3.19 13.66 ± 8.94 14.51 ± 8.30 10.80 ± 5.97 17.75 ± 7.55 15.5 ± 2.12 11.82 ± 8.64  
Age           
Mean ± SD 43 ± 12 30  ± 22 28  ± 13 42 ± 11 50 ± 12 54  ± 19 55  ± 14 59  ± 28 42 ± 14  
Non-S: Non-specific tissues; IDC: Invasive ductal carcinoma; Gyn: Gynecomastia; Fad: Fibroadenomas; DCIS: Ductal carcinoma in situ; ILC: Invasive lobular carcinoma; SD: Standard deviation 
 
Table 2. Clinicopathologic features of malignant samples 
Variables 
IDC ILC DCIS PC Total 
P-value 
Frequency (%) Frequency (%) Frequency (%) Frequency (%) Frequency (%) 
Grade      0.122 
1 6 (12) 0 (0) 0 (0) 0 (0) 6 (9.2) 
2 2 (40) 5 (100) 5 (62.5) 2 (100) 32 (49.2) 
3 24 (48) 0 (0) 3 (37.5) 0 (0) 27 (41.5) 
Lymph node involvement       
+ 32 (64) 2 (40) 2 (25) 0 (0) 36 (55.4) 0.059 
- 18 (36) 3 (60) 6 (75) 2 (100) 29 (44.6) 
Vascular or perineural invasion       
+ 23 (46) 0 (0) 2 (25) 0 (0) 25 (38.5) 0.103 
- 27 (54) 2 (100) 6 (75) 2 (100) 40 (61.5) 
Mass size       
Mean ± SD 14.51 ± 8.30 10.80 ± 5.97 17.75 ± 7.55 15.5  ± 2.12 11.82 ± 8.64  
Tumor size       
Mean ± SD 3.176 ± 2.970 3.80 ± 3.17 4.00  ± 3.61 2.45 ± 2.89 3.30 ± 3.01  
Age       
Mean ± SD 50 ± 12 54 ± 19 55 ± 14 59 ± 28 51 ± 13  
IDC: Invasive ductal carcinoma; DCIS: Ductal carcinoma in situ; ILC: Invasive lobular carcinoma; SD: Standard deviation 
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Table 3. Relationship between invasion of tumor and tumor grade, lesion site and age 
Variables 





Frequency (%) Frequency (%) Frequency (%) Frequency (%) 
Grade      0.086 
1 5 (83.3) 1 (16.7) 0.047 3 (50) 3 (50) 
2 13 (40.6) 19 (59.4) 8 (25) 24 (75) 
3 18 (66.7) 9 (33.3) 14 (51.9) 13 (48.1) 
Total 36 (55.4) 29 (44.6) 25 (38.5) 40 (61.5) 
Location       
Right 22 (61.1) 14 (38.9) 0.327 14 (38.9) 22 (61.6) 1.000 
Left 14 (48.3) 15 (51.7) 11 (37.9) 18 (62.1) 
Total 36 (55.4) 29 (44.6) 25 (38.5) 40 (61.5) 
Age       
Mean ± SD 48 ± 12 55 ± 13 0.058 50 ± 13 52 ± 13 0.618 
Age group       
< 50 21 (65.6) 11 (34.4) 0.136 12 (37.5) 20 (62.5) 1.000 
> 50 15 (45.5) 18 (54.5) 13 (39.4) 20 (60.6) 
SD: Standard deviation 
 
After dividing patients into two age groups above 
50 and younger than 50 years old and examining its 
relationship with the lymph node invasion and vascular 
or perineural invasion, following results were obtained: 
21 samples (65.6%) out of patients under the age 50 
years had lymph node metastasis and 11 samples 
(34.4%) without lymph node metastasis. Among 
patients older than 50 years, 15 samples (45.5%) had 
lymph node metastasis and 18 (54.5%) without lymph 
node metastasis. The results from this study were not 
statistically significant (P = 0.136). 12 out of 32 
patients (37.5%) younger than 50 years had invasion 
and 20 (62.5%) without it. Among patients older than 
50 years, 13 cases (39.4%) had invasion and 20 
(60.6%) had no invasion. The results of this survey 
were not statistically significant (Table 3) (P = 1.000). 
About the Nottingham score in the samples,  
1 sample (1.5%) obtained score 3, 5 samples (7.7%) 
score 5, 24 (36.9%) score 6, 8 samples (12.3%) score 7, 
21 samples (32.3%) score 8, and 6 samples (9.2%) 
score 9. About tubular formation, 1 sample (1.5%) 
obtained score 1, 31 samples (47.7%) score 2 and 33 
sample (50.8%) score 3. About mitotic rate in 
malignant tissues 11 samples (16.9%) had score 1, 38 
samples (58.5%) had score 2 and 16 samples (24.6%) 
had score 3. About nuclear grade in malignant tissues, 
2 samples (3.1%) obtained score 1, 39 samples (60%) 
score 2 and 24 samples (36.9%) had score 3 (Tables 4 
and 5). As shown in table 5, the samples with scores 3 
to 5 in Nottingham Score have a grade 1, score 6 and 7 
grade 2 and scores 8 and 9 grade 3 that are fully 
consistent with the Nottingham grading system or the 
Elston-Ellis modification of the Scarff-Bloom 
Richardson grading system. 
 
Discussion 
Complete and accurate pathology report has an 
important role in the treatment and determining the 
prognosis of patients with various breast lesions (10). 
Importance of factors such as tumor size, cell 
differentiation grade, lymph node metastasis, vascular 
or perineural invasion in the prognosis and life 
expectancy, and survival of patients with breast cancer 
is well understood (16). In several studies conducted in 
different countries, addressing these factors was 
different and most studies in this field through 
reviewing pathological reports were like the present 
study (17). This study is conducted aiming to examine 
the breast pathology reports and determine the 
frequency of various breast diseases and its relationship 
with some clinicopathologic parameters in Imam Reza 
Hospital of army of the Islamic Republic of Iran in a 
period of 4 years. The problem with this study is the 
small sample size with DCIS and ILC diagnosis and 
given that this study was conducted on samples 
collected over 4 years, this is partly justified. 
The mean age of patients was 42 ± 14, which was 
consistent with the studies conducted in Iran and other 
studies (18). 
 
Table 4. Nottingham scores in malignant samples 
Variables 
1 2 3 Total 
Frequency (%) Frequency (%) Frequency (%) Frequency (%) 
Tubular formation 1 (1.5) 31 (47.7) 33 (50.8) 65 (100) 
Mitotic rate 11 (16.9) 38 (58.5) 16 (24.6) 65 (100) 
Nuclear grade 2 (3.1) 39 (60) 24 (36.9) 65 (100) 
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Table 5. Relation between Nottingham score and tumor grade 
Score Frequency (%) Grade Frequency (%) 
3 1 (1.5) 1 6 (9.2) 
4 0 (0) 
5 5 (7.7) 
6 24 (36.9) 2 32 (49.2) 
7 8 (12.3) 
8 21 (32.3) 3 27 (41.5) 
9 6 (9.2) 
 
After dividing patients into two age groups below 
and above 50, it was observed that the frequency of 
non-specific tissue, fibroadenoma, fibrocystic, and 
gynecomastia changes was significantly more common 
in age group under 50. This was consistent with similar 
studies in this field (11,12). The mean age of patients 
with breast cancer was 51 which are higher compared 
to a mean age of patients with benign lesions that are 
38 years old. 
As you can see in table 1, the gender of patients 
with gynecomastia is male and in other cases, the 
number of female patients is significantly greater than 
the results are consistent with studies by Swerdloff and 
Makki in this field (19,20). 
Only two papillary carcinomas existed from all 
tumoral tissues that it was expected due to the spread 
of the tumor among the types of breast cancer (20). 
There was no relationship between the breast tumor 
site and final diagnosis, lymph node metastasis, 
vascular or perineural invasion that it was consistent 
with previous similar studies (21). 
There was no relationship in tumoral tissue between 
the final diagnosis and tumor grade, lymph node 
metastasis, vascular perineural invasion that this case 
was in previous studies (22). 
A significant correlation existed between tumor 
grade and lymph node metastasis so that tumors with 
higher grades were more involved in lymph nodes. 
This was consistent with previous similar studies, but 
there was no significant relationship between higher 
tumor grade and vascular or perineural invasion. This 
was not consistent with previous studies in this area 
(23-27). 
Checking the histological differentiation of 
malignant samples showed that about 90% of the 
samples had grades 2 and 3 and given the direct impact 
of the tissue differentiation grade on patient survival 
and prognosis of the disease, if we can diagnose the 
disease at earlier stages by developing the necessary 
training in relation to breast cancer screening and self-
examination, the burden of disease and adverse effects 
of breast cancer in society can be dramatically reduced, 
and the survival of patients can be increased. 
In this study, a statistically significant relationship 
exists between the patient sex and final diagnosis, 
patient age group and final diagnosis, and cell 
differentiation grade and lymph node metastasis along 
with samples. In the pathology reports in the center, 
cell differentiation grade of tumor was completely 
matched with Nottingham Grading System. Since only 
9.2% of samples were diagnosed in grade 1, it is hoped 
to focus more on breast cancer screening methods and 
breast cancer self-examination and help to a large 
extent to the early detection of the disease in earlier 
stages. It is hoped to look at this study as a prospective 
study with a larger sample size and more variables of 
clinicopathologic parameters, so to better know the 
preventive factors and factors affecting the prognosis 
of the types of breast diseases with the help of data 
from these studies. 
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